Editorial: Galactorrhea-amenorrhea, brom-ergocryptine, and the dopamine receptor.
D000568:Amenorrhea / Q000188:drug therapy* / Q000209:etiology; D001921:Brain / Q000378:metabolism; D001971:Bromocriptine / Q000494:pharmacology / Q000627:therapeutic use*; D003864:Depression, Chemical; D004298:Dopamine / Q000378:metabolism*; D004873:Ergolines / Q000627:therapeutic use*; D005260:Female; D005687:Galactorrhea / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D007775:Lactation Disorders / Q000188:drug therapy*; D008297:Male; D011247:Pregnancy; D011388:Prolactin / Q000378:metabolism*; D011955:Receptors, Drug; D013577:Syndrome
D004873:Ergolines; D011955:Receptors, Drug; D001971:Bromocriptine; D011388:Prolactin; D004298:Dopamine